Cell-based analysis of Chikungunya virus E1 protein in membrane fusion
© Kuo et al; licensee BioMed Central Ltd. 2012
Received: 13 February 2012
Accepted: 21 April 2012
Published: 21 April 2012
Chikungunya fever is a pandemic disease caused by the mosquito-borne Chikungunya virus (CHIKV). E1 glycoprotein mediation of viral membrane fusion during CHIKV infection is a crucial step in the release of viral genome into the host cytoplasm for replication. How the E1 structure determines membrane fusion and whether other CHIKV structural proteins participate in E1 fusion activity remain largely unexplored.
A bicistronic baculovirus expression system to produce recombinant baculoviruses for cell-based assay was used. Sf21 insect cells infected by recombinant baculoviruses bearing wild type or single-amino-acid substitution of CHIKV E1 and EGFP (enhanced green fluorescence protein) were employed to investigate the roles of four E1 amino acid residues (G91, V178, A226, and H230) in membrane fusion activity.
Western blot analysis revealed that the E1 expression level and surface features in wild type and mutant substituted cells were similar. However, cell fusion assay found that those cells infected by CHIKV E1-H230A mutant baculovirus showed little fusion activity, and those bearing CHIKV E1-G91D mutant completely lost the ability to induce cell-cell fusion. Cells infected by recombinant baculoviruses of CHIKV E1-A226V and E1-V178A mutants exhibited the same membrane fusion capability as wild type. Although the E1 expression level of cells bearing monomeric-E1-based constructs (expressing E1 only) was greater than that of cells bearing 26S-based constructs (expressing all structural proteins), the sizes of syncytial cells induced by infection of baculoviruses containing 26S-based constructs were larger than those from infections having monomeric-E1 constructs, suggesting that other viral structure proteins participate or regulate E1 fusion activity. Furthermore, membrane fusion in cells infected by baculovirus bearing the A226V mutation constructs exhibited increased cholesterol-dependences and lower pH thresholds. Cells bearing the V178A mutation exhibited a slight decrease in cholesterol-dependence and a higher-pH threshold for fusion.
Cells expressing amino acid substitutions of conserved protein E1 residues of E1-G91 and E1-H230 lost most of the CHIKV E1-mediated membrane fusion activity. Cells expressing mutations of less-conserved amino acids, E1-V178A and E1-A226V, retained membrane fusion activity to levels similar to those expressing wild type E1, but their fusion properties of pH threshold and cholesterol dependence were slightly altered.
KeywordsAlphavirus Bicistronic baculovirus expression system Chikungunya virus Class II fusion protein Fusion peptide Membrane fusion
Chikungunya virus (CHIKV) is an enveloped plus-stranded RNA virus classified into the genus Alphavirus of family Togaviridae. The CHIKV genomic organization is arranged as with other alphaviruses: "5'-nsP1-nsP2-nsP3-nsP4-junction region-C-E3-E2-6K-E1-poly (A)-'3 " . The first open reading frame (ORF) of the genome encodes a polyprotein to yield all non-structural proteins nsP1 to nsP4. A subgenomic RNA containing the second ORF encodes a polyprotein that produces the structural proteins, including capsid protein (C) and two envelope proteins (E2 and E1) . E2 and E1 are glycoproteins embedded in the viral membrane in a heterodimeric form and are responsible for viral attachment and membrane fusion, respectively . Viral membrane fusion with a cell membrane is mediated by the E1 glycoprotein, a class II fusion protein [3–5], in a process dependent on low-pH. Acidic conditions induce a conformational change in the viral envelope proteins, dissociation of the E2-E1 heterodimers, and formation of E1 homotrimers [6–8]. The E1 trimer inserts into the target membrane via its hydrophobic fusion peptide and refolds to form a hairpin-like structure [9, 10]. In addition to the dependence on low pH for viral membrane fusion, cholesterol is also required for both cell membrane fusion and budding during alphavirus infection [11–14].
Chikungunya fever manifests after a bite by a CHIKV-infected Aedes mosquito, and is associated with clinical symptoms including fever, headache, myalgia, and joint pains . An expanding worldwide pattern of CHIKV epidemics has been reported . A recent E1-A226V mutant virus outbreak emerged in the Indian Ocean where the virus had adapted to a broadly distributed vector, A. albopictus[17–19]. The CHIKV viral infection's geographical expansion was facilitated by E1-A226V mutant expressing high vector competence towards A. albopictus. E2-I211T and E1-T98A mutants have an epistatic interaction with the E1-A226V mutation that influences CHIKV fitness in A. albopictus[20, 21]. Additional lines of evidence from related alphavirus, Semliki forest virus (SFV) and Sindbis virus (SINV), show that the valine residue at position 226 of the E1 glycoprotein, controls the cholesterol dependence of viral-cell membrane fusion [22, 23]. Thus, the CHIKV E1-A226V mutation has the potential to alter E1's biological properties including fusogenicity, which may explain the adaptation mechanism seen in A. albopictus.
Viral fusion proteins contain a "fusion" amino acid sequence. For example, a recent study demonstrated that the HIV fusion peptide at the gp41 N-terminus, a glycine-rich hydrophobic sequence, is a critical determinant of HIV-infected cell membrane fusion . Substitution of glutamic acid for glycine in the fusion sequence of influenza virus HA2, prevents cell fusion in simian cells . In alphaviruses, E1 also contains a highly conserved fusion peptide within a hydrophobic region of 19 amino acids that span amino acid residues 83 through 101 . SFV E1-G91D, a glycine within the fusion peptide loses its fusion activity on substitution with glutamic acid . However, SFV E1 srf-3 (sterol requirement in function) mutant (P226S) and srf-5 mutant (V178A), two substituted amino acids located outside of fusion sequences, were identified by cholesterol-depletion experiments in mosquito cell lines; both mutants show decreased fusogenicity related cholesterol-dependence [22, 28]. The recently identified CHIKV A226V mutant may be selected by the adaptation to A. albobilicus[17, 29, 30]. Although the crystal structures of CHIKV glycoproteins have been determined, the detailed functional relationship between structure and fusogenicity on CHIKV E1 protein remains unclear .
To explore the structure and fusogenicity of the E1 protein, four E1 residues (G91, V178, A226, and H230) were selected for change by mutation. Mutants were tested for their ability to induce cell membrane fusion. Constructs expressing the wild type protein E1, or a single-amino-acid substitution, either in monomeric-E1 form or with two other structural proteins (capsid protein C and envelope protein E2), were introduced into a bicistronic baculovirus expression system  to produce recombinant baculoviruses for cell-based assay . A bicistronic baculovirus expression system co-expressing CHIKV structural proteins and EGFP (enhanced green fluorescence protein) easily identified EGFP-positive Sf21 cells that simultaneously expressed E1 and E2 on the cell surfaces . Use of this system facilitated our analysis of the E1 fusogenicity determinant, and revealed that changes in E1 conserved amino acids (G91 and H230) resulted in losing all fusogenicity.
Site-directed mutagenesis and plasmid constructs
Recombinant virus production and titer determination
The production and titer determination of recombinant viruses were as described previously . Baculoviruses derived from monomeric-E1-based constructs were named vE1-WT, vE1- A226V, vE1-V178A, vE1-H230A, and vE1-G91D, while those derived from 26S-based constructs were named vS-WT, vS-A226V, and vS-V178A. The recombinant viruses were purified by a series of three end-point dilutions. Sequences of all recombinant viruses were confirmed by viral DNA sequencing. In brief, viral genomic DNAs of recombinant baculoviruses were purified using a QIAamp genomic DNA purification kit (Qiagen, Hilden, Germany), and then used as templates for PCR amplification using Phusion High-Fidelity DNA Polymerase. The amplified DNA fragments were sequenced using the dideoxy chain-termination method.
Cell surface biotinylation
Cell surface proteins were biotinylated using literature methods . Sf-21 cells, an insect cell line commonly used for baculovirus infection, were seeded at 2 × 106 cells/well in a 6-well plate and infected with recombinant baculoviruses at a multiplicity of infection (M.O.I.) of one in Sf-900 II SFM, containing 8% fetal calf serum (FCS) at pH 6.4. At two days post infection (dpi), cells were washed twice with PBS (2 ml, pH 7.4), then incubated with 200 μl PBS (pH 7.4) containing EZ-Link Sulfo-NHS-LC-Biotin (0.5 mg/ml) (Pierce Chemical, Rockford, IL) at 4°C for 30 minutes. The incubated cells were washed twice with glycine in PBS (2 ml, 100 mM, pH 7.1) to stop biotinylation. Cells were then lysed in 250 μl RIPA buffer (Thermo Scientific, Rockford, IL) containing an EDTA-free Protease Inhibitor Cocktail (Roche, Mannheim, Germany). The lysates were sonicated on ice using a Microson XL 2005 ultrasonic cell disruptor equipped with a P1 microprobe (Heat Systems Inc., NY) at 14 W for 10 seconds. Samples were then centrifuged at 15000 rpm for 15 minutes. The resulting pellets were dissolved into urea (200 μl, 8 M) and re-centrifuged at 15000 rpm for 15 minutes to remove un-dissolved materials. Fifty-microliter aliquots of the supernatant were mixed with PBS (350 μl, pH 7.4). Biotinylated cell surface proteins in supernatant were separated from non-biotinylated proteins by precipitation with 50 μl M-280 streptavidin magnetic beads (Invitrogen Dynal AS, Oslo, Norway) at 4°C for 60 minutes. Beads were washed three times with 0.5 ml PBS. Biotinylated E1 proteins were then eluted by boiling the beads in 50 μl 2 × Laemmli sample buffer containing 4 M urea, resolved by 10% SDS-PAGE, and detected by Western blot using rabbit anti-CHIKV E1. The same blot was re-probed by mAb anti-gp64 (AcV5 sc-65499; Santa Cruz, CA) as a control for total protein loading.
Western blot analysis
Western blot analysis was performed as previously reported  with modifications. Sf21 cells were seeded at 1 × 106 cells/well in a 24-well plate and infected with recombinant viruses at an M.O.I. of one. Total proteins harvested at 2 dpi were dissolved in Laemmli sample buffer containing 4 M urea and separated onto 10% SDS-PAGE. The blotted membranes were incubated with rabbit anti-CHIKV E1 serum (1/500), anti-CHIKV E2 serum (1/500), or anti-gp64 monoclonal antibody (1/2000) (Santa Cruz Biotechnology, Inc, Santa Cruz, CA). The membranes were then incubated at a 1:1000 dilution with Peroxidase-conjugated Goat anti-Rabbit IgG (Jackson ImmunoResearch Laboratories, Inc., Philadelphia, Pa) or peroxidase-conjugated anti-mouse IgG (KPL, Gaithersburg, MD) for one hour at room temperature. Peroxidase was detected on the membrane using a LumiFast Plus Chemiluminescence Detection Kit (T-Pro Biotechnology, Taiwan, ROC) following the manufacturer's protocol. The UVP AutoChemi Image System was used for capturing and processing the various images.
For CHIKV E1 protein staining the cell surface, Sf21 cells were seeded in a 96-well plate and infected with recombinant baculoviruses at an M.O.I. of one in Sf-900 II (pH 6.4) containing 2% FCS. At two dpi, cells were fixed with 3% formaldehyde and stained with rabbit anti-whole CHIKV serum at a dilution of 1:100 for 30 minutes at room temperature. After washing twice with cold PBS, cells were incubated with the secondary antibody, Alexa Fluor 594-conjugated goat anti-rabbit IgG (Invitrogen, Molecular Probes, Carlsbad, CA) at a dilution of 1:500 for 30 minutes at room temperature and then washed twice with cold PBS. The stained cells were recorded using an inverted fluorescence microscope (Olympus Model IX71, Tokyo, Japan), red-channel for CHIKV E1 staining and green-channel for EGFP.
Cell-cell fusion assay
CHIKV E1 fusion activity, expressed on the baculovirus-infected Sf21 cell surfaces was examined using a cell-cell fusion assay as previously described . Briefly, Sf21 cells were infected with indicated recombinant baculoviruses at an M.O.I. of one in Sf-900 II SFM, with or without FCS. After one dpi, the culture medium was replaced with Sf-900 II SFM containing either 2% FCS, cholesterol (100 μg/ml) and indicated pH levels for pH-dependence assay, or containing indicated concentrations of cholesterol for cholesterol-dependence assay. The syncytial formations were examined and photographed using an inverted fluorescence microscope (Olympus Model IX71, Tokyo, Japan). Calculation of the fusion index was modified from previous reports [25, 35]. Briefly, the average size of a single cell was determined by the formula: Total area of 100 Sf21 cells/100. The number and area of single-cell or syncytia were counted and measured using ImageJ software . The number of EGFP positive nuclei was calculated by: total areas containing at least 100 cells/average single-cell size. The fusion index was calculated using: 1-(number of EGFP positive cells/number of EGFP positive nuclei). In the comparisons of syncytial cell size, cell number, and total area, at least 100 EGFP positive single cells were counted and measured. The average size of syncytial cells was calculated as: total area/number of cells.
Construction of recombinant baculovirus vectors that express mutant E1 protein
To evaluate the influence of residues at positions 91, 178, 226, and 230 of E1 protein on cell fusion, we used site-directed mutagenesis to generate pE1-A226V, pE1-V178A, pE1-G91D, and pE1-H230A mutants in the CHIKV E1 gene. Mutants were cloned into the bicistronic baculovirus expression vector: pBac-Rhir-E (Figure 1 bottom line), which only expresses E1 protein. E1-A226V and E1-V178A mutations were also introduced into 26S-based constructs, which express all structural proteins, to furnish pS-A226V and pS-V178A (Figure 1), respectively. These clones were used to investigate possible effects of other CHIKV structural proteins on E1-mediated membrane fusion.
Synthesis and cell surface expression of wild type and mutant E1 protein
To test whether these E1 proteins were targeted to the cell surface, we performed biotin labeling on the cell surface followed by Western blot analysis. Results showed that both E1 proteins (wild type or substituted form) and the gp64 control protein were labeled with biotin (Figure 3B), indicating that all forms of E1 protein were located on the cell surface. To confirm these results, we conducted immunofluorescence microscopy using antibodies conjugated with Alexa Fluor 546 to detect the E1 cell surface. Figure 3C shows that red signals, from E1 present at the cell surface, either in wild type or in mutants, were observed for cells infected by the corresponding recombinant baculovirus under a fluorescence microscope (indicated by arrows). However, no red signal was detected in cells infected by control baculoviruses (lower right panel), indicating that both wild type and mutant E1 proteins were targeted to the cell surface.
Fusion activities and properties of wild type and mutant E1 expressed by monomeric-based constructs
To analyze whether E1-A226 and E1-V178 protein's pH and cholesterol dependency differ from those of wild-type E1 protein, cells were incubated with medium containing 200 μg/ml cholesterol at various pH values (ranging from pH 5.8 to pH 6.9), or at a constant pH of 5.9 with varying concentrations of cholesterol (ranging from 0 to 100 μg/ml). Cell fusion capacity was analyzed by fluorescence microscopy and fusion indexes were determined. To attain 100% cell fusion, cells expressing E1-A226V required a slightly lower pH than those expressing wild type E1 or E1-V178A (pH = 6.2 vs. pH = 6.4) (Figure 4B). Cells expressing wild type E1, E1-V178A, and E1-A226V required 50 μg/ml cholesterol to achieve 100% cell fusion. Nevertheless, cholesterol dependence was lower in cells expressing E1-V178A to attain 60% cell fusion, compared to cells expressing either wild-type E1 or E1-A226V (Figure 4C). No cell fusion was observed in cells expressing G91D or H230A (Figure 4C).
E1 co-expression with other CHIKV structural proteins exhibits different membrane fusion properties
In this study, we studied the roles of four amino acids of CHIKV E1 protein (G91, V178, A226, and H230) in cell fusion using an insect cell-based system . This cell-based system revealed three important features of CHIKV E1 protein in membrane fusion. First, the highly conserved amino acid residues, G91 and H230, are important for membrane fusion functionality. Substitution of glycine with glutamic acid in the fusogen peptide disrupts the hydrophobic sequence, causing a loss of E1 fusogenicity (Figure 3A), which is consistent with the results of a study involving SFV G91D . Although the histidine residue at E1 230 is located outside of the fusion sequence, the bending role of histidine cannot be substituted for by alanine. When we replaced the histidine residue, E1 fusogenicity almost vanished (Figure 4A).
Second, the less-conserved amino acid residues (V178 and A226) can be replaced without losing E1 fusion capacity (Figure 4A). However, substitution of these residues changes E1's fusion dependencies on pH and cholesterol (Figure 4B). Third, other CHIKV structural proteins influence E1 fusogenic capacity (Figure 6B). SFV srf-5 mutants (V178A) are associated with decreased cholesterol-dependence on viral membrane fusion . However, the CHIKV E1-V178A mutant exhibits changes in pH-dependence, but no significant differences in cholesterol-dependence occur. Our finding that CHIKV A226V mutant required more acidic pH conditions, together with greater cholesterol concentrations to trigger fusion activity (Figure 4C and Figure 7) could explain a previous report that infection with CHIKV A226V mutant is associated with a low viral titre compared to wild-type CHIKV infection of cholesterol-depleted C6/36 cells . Limitations of an A226V mutant infection of cholesterol-depleted C6/36 cells may result in the viral fusion step having increased cholesterol-dependence. However, Tsetsarkin et al. demonstrated that CHIKV adaptation to A. albopictus mosquitoes does not correlate with acquisition of cholesterol dependence or low-pH thresholds for membrane fusion . The observation of larger syncytia, induced by co-expression of E1 with E2, supports the observation that alphavirus E2 proteins both facilitate E1 folding and regulate E1 fusogenic properties, including cholesterol dependence.
Blissard and Wenz classified fusion induced by viral membrane fusion as "fusion from within" (FFWI), requiring viral fusogen synthesis. The authors defined "Fusion from without" (FFWO) as exogenous fusogen . FFWI can be triggered by endogenous fusogen if delivered by authentic viral infection, transfection, or other virus-based vehicle. In this study, CHIKV E1 FFWI was triggered by a baculovirus-based vector containing a bicistronic co-expression system, so providing a new model that describes class II viral membrane fusion. The baculovirus-based vehicle is an efficient way to express fusogen on the cell surface without completion of the CHIKV replication cycle. A similar baculovirus-expression system has been used to express CHIKV E1 and E2 proteins in the development of a subunit vaccine to prevent CHIKV infection . We applied the cell-based assay to compare the E1 fusogenicities of CHIKV and VEEV, and our findings were in agreement with a previous study that VEEV is insensitive to cholesterol depletion . We also found that heparin and other polysaccharides could block cell fusion by VEEV E1 proteins, without inhibiting CHIKV E1-mediated membrane fusion (unpublished data). We therefore believe that cell-based assay using a baculovirus bicistronic vector is a safe and easy system for high throughput screening for agents that can block membrane fusion by CHIKV and other alphaviruses.
In summary, we demonstrated that mutation of highly conserved amino acids of CHIKV E1 across 15 other alphaviruses, i. e., G91 and H230, lost the membrane fusion activity. In contrast, the less conserved amino acid residues (V178 and A226) were replaceable by other amino acid without losing fusion activity but changing in cholesterol and pH dependency slightly. The presence of other structural protein, E2, could enhance E1 fusion activity.
Semiliki forest virus
Venezuelan equine encephalitis virus
Sterol requirement in function
Multiplicity of infection
Enhanced green fluorescence protein
Fetal calf serum
Days post infection.
We thank Dr. Simon Silver (visiting professor from Chang Gung University) and Dr. Victor Stollar (UMDNJ-Robert Wood Johnson Medical School, New Jersey, USA) for their help in revising this manuscript. This work was supported by grants from The National Science Council and The Center of Excellence Program on Membrane Technology, the Ministry of Education to TYW, and BMRP grants from the Chang Gung Memorial Hospital and the Ministry of Education to SJ L.
- Powers AM, Brault AC, Shirako Y, Strauss EG, Kang W, Strauss JH, Weaver SC: Evolutionary relationships and systematics of the alphaviruses. J Virol. 2001, 75: 10118-10131. 10.1128/JVI.75.21.10118-10131.2001.PubMed CentralView ArticlePubMed
- Li L, Jose J, Xiang Y, Kuhn RJ, Rossmann MG: Structural changes of envelope proteins during alphavirus fusion. Nature. 2010, 468: 705-708. 10.1038/nature09546.PubMed CentralView ArticlePubMed
- Klimjack MR, Jeffrey S, Kielian M: Membrane and protein interactions of a soluble form of the Semliki Forest virus fusion protein. J Virol. 1994, 68: 6940-6946.PubMed CentralPubMed
- Omar A, Koblet H: Semliki Forest virus particles containing only the E1 envelope glycoprotein are infectious and can induce cell-cell fusion. Virology. 1988, 166: 17-23. 10.1016/0042-6822(88)90141-9.View ArticlePubMed
- Sanz MA, Rejas MT, Carrasco L: Individual expression of sindbis virus glycoproteins. E1 alone promotes cell fusion. Virology. 2003, 305: 463-472. 10.1006/viro.2002.1771.View ArticlePubMed
- Sanchez-San Martin C, Liu CY, Kielian M: Dealing with low pH: entry and exit of alphaviruses and flaviviruses. Trends Microbiol. 2009, 17: 514-521. 10.1016/j.tim.2009.08.002.View ArticlePubMed
- Wahlberg JM, Garoff H: Membrane fusion process of Semliki Forest virus.I: low pH-induced rearrangement in spike protein quaternary structureprecedes virus penetration into cells. J Cell Biol. 1992, 116: 339-348. 10.1083/jcb.116.2.339.View ArticlePubMed
- Wahlberg JM, Bron R, Wilschut J, Garoff H: Membrane fusion of Semliki Forest virus involves homotrimers of the fusion protein. J Virol. 1992, 66: 7309-7318.PubMed CentralPubMed
- Bressanelli S, Stiasny K, Allison SL, Stura EA, Duquerroy S, Lescar J, Heinz FX, Rey FA: Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J. 2004, 23: 728-738. 10.1038/sj.emboj.7600064.PubMed CentralView ArticlePubMed
- Gibbons DL, Vaney MC, Roussel A, Vigouroux A, Reilly B, Lepault J, Kielian M, Rey FA: Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. Nature. 2004, 427: 320-325. 10.1038/nature02239.View ArticlePubMed
- Chatterjee PK, Vashishtha M, Kielian M: Biochemical consequences of a mutation that controls the cholesterol dependence of Semliki Forest virus fusion. J Virol. 2000, 74: 1623-1631. 10.1128/JVI.74.4.1623-1631.2000.PubMed CentralView ArticlePubMed
- Kielian MC, Helenius A: Role of cholesterol in fusion of Semliki Forest virus with membranes. J Virol. 1984, 52: 281-283.PubMed CentralPubMed
- Smit JM, Bittman R, Wilschut J: Low-pH-dependent fusion of Sindbis virus with receptor-free cholesterol- and sphingolipid-containing liposomes. J Virol. 1999, 73: 8476-8484.PubMed CentralPubMed
- White J, Helenius A: pH-dependent fusion between the Semliki Forest virus membrane and liposomes. Proc Natl Acad Sci USA. 1980, 77: 3273-3277. 10.1073/pnas.77.6.3273.PubMed CentralView ArticlePubMed
- Her Z, Kam YW, Lin RT, Ng LF: Chikungunya: a bending reality. Microbes Infect. 2009, 11: 1165-1176. 10.1016/j.micinf.2009.09.004.View ArticlePubMed
- Schwartz O, Albert ML: Biology and pathogenesis of chikungunya virus. Nat Rev Microbiol. 2010, 8: 491-500. 10.1038/nrmicro2368.View ArticlePubMed
- Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney MC, Lavenir R, Pardigon N, Reynes JM, Pettinelli F: Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med. 2006, 3: e263-10.1371/journal.pmed.0030263.PubMed CentralView ArticlePubMed
- Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S: A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 2007, 3: e201-10.1371/journal.ppat.0030201.PubMed CentralView ArticlePubMed
- Vazeille M, Moutailler S, Coudrier D, Rousseaux C, Khun H, Huerre M, Thiria J, Dehecq JS, Fontenille D, Schuffenecker I: Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus. PLoS One. 2007, 2: e1168-10.1371/journal.pone.0001168.PubMed CentralView ArticlePubMed
- Tsetsarkin KA, McGee CE, Volk SM, Vanlandingham DL, Weaver SC, Higgs S: Epistatic roles of E2 glycoprotein mutations in adaption of chikungunya virus to Aedes albopictus and Ae. aegypti mosquitoes. PLoS One. 2009, 4: e6835-10.1371/journal.pone.0006835.PubMed CentralView ArticlePubMed
- Tsetsarkin KA, Chen R, Leal G, Forrester N, Higgs S, Huang J, Weaver SC: Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes. Proc Natl Acad Sci USA. 2011, 108: 7872-7877. 10.1073/pnas.1018344108.PubMed CentralView ArticlePubMed
- Chatterjee PK, Eng CH, Kielian M: Novel mutations that control the sphingolipid and cholesterol dependence of the Semliki Forest virus fusion protein. J Virol. 2002, 76: 12712-12722. 10.1128/JVI.76.24.12712-12722.2002.PubMed CentralView ArticlePubMed
- Lu YE, Cassese T, Kielian M: The cholesterol requirement for sindbis virus entry and exit and characterization of a spike protein region involved in cholesterol dependence. J Virol. 1999, 73: 4272-4278.PubMed CentralPubMed
- Torres O, Bong D: Determinants of membrane activity from mutational analysis of the HIV fusion peptide. Biochemistry. 2011, 50: 5195-5207. 10.1021/bi200696s.View ArticlePubMed
- Gething MJ, Doms RW, York D, White J: Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus. J Cell Biol. 1986, 102: 11-23. 10.1083/jcb.102.1.11.View ArticlePubMed
- Voss JE, Vaney MC, Duquerroy S, Vonrhein C, Girard-Blanc C, Crublet E, Thompson A, Bricogne G, Rey FA: Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature. 2010, 468: 709-712. 10.1038/nature09555.View ArticlePubMed
- Levy-Mintz P, Kielian M: Mutagenesis of the putative fusion domain of the Semliki Forest virus spike protein. J Virol. 1991, 65: 4292-4300.PubMed CentralPubMed
- Vashishtha M, Phalen T, Marquardt MT, Ryu JS, Ng AC, Kielian M: A single point mutation controls the cholesterol dependence of Semliki Forest virus entry and exit. J Cell Biol. 1998, 140: 91-99. 10.1083/jcb.140.1.91.PubMed CentralView ArticlePubMed
- Santhosh SR, Dash PK, Parida M, Khan M, Rao PV: Appearance of E1: A226V mutant Chikungunya virus in Coastal Karnataka, India during 2008 outbreak. Virol J. 2009, 6: 172-10.1186/1743-422X-6-172.PubMed CentralView ArticlePubMed
- Santhosh SR, Dash PK, Parida MM, Khan M, Tiwari M, Lakshmana Rao PV: Comparative full genome analysis revealed E1: A226V shift in 2007 Indian Chikungunya virus isolates. Virus Res. 2008, 135: 36-41. 10.1016/j.virusres.2008.02.004.View ArticlePubMed
- Kuo SC, Chen YJ, Wang YM, Kuo MD, Jinn TR, Chen WS, Chang YC, Tung KL, Wu TY, Lo SJ: Cell-based analysis of Chikungunya virus membrane fusion using baculovirus-expression vectors. J Virol Methods. 2011, 175: 206-215. 10.1016/j.jviromet.2011.05.015.View ArticlePubMed
- Chen YJ, Chen WS, Wu TY: Development of a bi-cistronic baculovirus expression vector by the Rhopalosiphum padi virus 5' internal ribosome entry site. Biochem Biophys Res Commun. 2005, 335: 616-623. 10.1016/j.bbrc.2005.07.116.View ArticlePubMed
- Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning-A Laboratory Manual. 1989, NY: Cold Spring Harbor Laboratory Press, 2
- Cho JA, Osenkowski P, Zhao H, Kim S, Toth M, Cole K, Aboukameel A, Saliganan A, Schuger L, Bonfil RD, Fridman R: The inactive 44-kDa processed form of membrane type 1 matrix metalloproteinase (MT1-MMP) enhances proteolytic activity via regulation of endocytosis of active MT1-MMP. J Biol Chem. 2008, 283: 17391-17405. 10.1074/jbc.M708943200.PubMed CentralView ArticlePubMed
- Zheng Y, Sanchez-San Martin C, Qin ZL, Kielian M: The Domain I-Domain III linker plays an important role in the fusogenic conformational change of the alphavirus membrane fusion protein. J Virol. 2011, 85: 6334-6342. 10.1128/JVI.00596-11.PubMed CentralView ArticlePubMed
- Rasband WS: ImageJ, U. S. National Institutes of Health. 2011, Bethesda, Maryland, USA, [http://imagej.nih.gov/ij/]
- Chanel-Vos C, Kielian M: A conserved histidine in the ij loop of the Semliki Forest virus E1 protein plays an important role in membrane fusion. J Virol. 2004, 78: 13543-13552. 10.1128/JVI.78.24.13543-13552.2004.PubMed CentralView ArticlePubMed
- Tsetsarkin KA, McGee CE, Higgs S: Chikungunya virus adaptation to Aedes albopictus mosquitoes does not correlate with acquisition of cholesterol dependence or decreased pH threshold for fusion reaction. Virol J. 2011, 8: 376-10.1186/1743-422X-8-376.PubMed CentralView ArticlePubMed
- Bratt MA, Gallaher WR: Preliminary analysis of the requirements for fusion from within and fusion from without by Newcastle disease virus. Proc Natl Acad Sci USA. 1969, 64: 536-543. 10.1073/pnas.64.2.536.PubMed CentralView ArticlePubMed
- Metz SW, Geertsema C, Martina BE, Andrade P, Heldens JG, van Oers MM, Goldbach RW, Vlak JM, Pijlman GP: Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells. Virol J. 2011, 8: 353-10.1186/1743-422X-8-353.PubMed CentralView ArticlePubMed
- Kolokoltsov AA, Fleming EH, Davey RA: Venezuelan equine encephalitis virus entry mechanism requires late endosome formation and resists cell membrane cholesterol depletion. Virology. 2006, 347: 333-342. 10.1016/j.virol.2005.11.051.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.